NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor
about
Loss of NAC1 expression is associated with defective bony patterning in the murine vertebral axisStructure of the human Nac1 POZ domainZinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis.Pathogenesis of ovarian cancer: clues from selected overexpressed genes.Nac1 interacts with the POZ-domain transcription factor, Miz1.Nucleus accumbens-1/GADD45GIP1 axis mediates cisplatin resistance through cellular senescence in ovarian cancer.Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous CarcinomasQuantitative proteomic analysis of ovarian cancer cells identified mitochondrial proteins associated with Paclitaxel resistance.Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinomaCell cycle-dependent alteration in NAC1 nuclear body dynamics and morphology.NAC1 modulates sensitivity of ovarian cancer cells to cisplatin by altering the HMGB1-mediated autophagic response.Effect of dietary restriction and subsequent re-alimentation on the transcriptional profile of hepatic tissue in cattle.An Optimization-Driven Analysis Pipeline to Uncover Biomarkers and Signaling Paths: Cervix Cancer.NAC1 is an actin-binding protein that is essential for effective cytokinesis in cancer cells.Mechanisms of ovarian cancer metastasis: biochemical pathways.Dysfunction of nucleus accumbens-1 activates cellular senescence and inhibits tumor cell proliferation and oncogenesis.Identification of potential biomarkers from microarray experiments using multiple criteria optimizationp38β, A novel regulatory target of Pokemon in hepatic cells.NAC-1, a potential stem cell pluripotency factor, contributes to paclitaxel resistance in ovarian cancer through inactivating Gadd45 pathway.Identification of the NAC1-regulated genes in ovarian cancerThe critical role of oxidative stress in the toxicity and metabolism of quinoxaline 1,4-di-N-oxides in vitro and in vivo.Low expression of nucleus accumbens-associated protein 1 predicts poor prognosis for patients with pancreatic ductal adenocarcinoma.Nucleus accumbens associated 1 is recruited within the promyelocytic leukemia nuclear body through SUMO modification.Nucleus accumbens-associated protein-1 promotes glycolysis and survival of hypoxic tumor cells via the HDAC4-HIF-1α axis.Nac1 promotes self-renewal of embryonic stem cells through direct transcriptional regulation of c-Myc.Development of a novel ovarian cancer molecular target therapy against cancer-related transcriptional factor, NAC1.Silencing of NAC1 Expression Induces Cancer Cells Oxidative Stress in Hypoxia and Potentiates the Therapeutic Activity of Elesclomol.Nuclear localization signal in a cancer-related transcriptional regulator protein NAC1.Homeostatic regulatory role of Pokemon in NF-κB signaling: stimulating both p65 and IκBα expression in human hepatocellular carcinoma cells.Cancer-related transcription regulator protein NAC1 forms a protein complex with CARM1 for ovarian cancer progression.NACC1, as a Target of MicroRNA-331-3p, Regulates Cell Proliferation in Urothelial Carcinoma Cells
P2860
Q27311277-4D39FF70-4F81-49A5-B405-3DBD1373D0F1Q27655343-B189B92D-186D-4520-8166-F841031A296DQ31021133-8C00FAA8-F8B4-4EE1-B623-B3F946767803Q33651139-B7DD8E11-D236-4184-A6E8-D36EC236DE6BQ33713849-663FA2FC-BFA0-4684-9910-AD8DBD2FC484Q33751346-33026168-E138-4BAB-800C-5D6500104E7AQ33865070-7362AE66-FDC6-46C8-862C-19DE4640A420Q34339902-AD11E2D6-8C9A-4F53-8F21-659CC11E0C14Q34899256-93BA844C-8F12-4F9A-8ACD-BA1C01D2A396Q35188967-7A927090-AB54-47FB-93EE-A9429DB83938Q35745292-E148EFE8-9440-4342-A4E1-94CDA37B3CD9Q35960193-7175E2B3-ADF0-4195-AA68-F70EDD28ECFCQ36069642-CCE99054-13D4-4773-96D4-68B91A1F3D8AQ36170245-4C66C444-3B74-4A90-9108-61996C488788Q36321859-DFA02ED0-B368-4BFE-9E2F-76E7A82CA557Q36733968-8D244C0E-9D2B-4027-BC10-050A6D4B5981Q36804902-BE95F4B2-55C0-4BF1-835C-FAFD5D3C7675Q37091827-C282B1BF-6E22-42D3-8E5C-6C1C8CC59087Q37184393-8E9D2315-A3BA-43E9-B310-D032CB21B030Q37415453-B9633C9E-D632-4ED5-A2E3-6DF909773CDDQ38861229-54B7D746-04CF-4860-949E-C3EF92A8150BQ39223722-7F8EDD03-AE89-434E-8BD4-C2D0AACFD762Q41042814-0D547C7B-5FC8-4A6C-9FAE-F3161E20D888Q41193919-09F299C4-422A-4264-83BE-5405DBFBC7CFQ41471207-56B429D0-00FA-4AE6-A5AE-F9E6035F7D77Q43698158-56CDAC75-AE9F-4228-B1D1-1B143149FEBBQ46256712-CC4AC7EF-899E-4F69-A92C-E8E9E5027D1FQ50495781-0E47D46C-640B-491D-8016-4211ABCACED4Q51536324-B558548A-DD86-4838-9044-ADF70C4699BCQ55504453-7E958299-67EA-4165-A765-84CF248E4EF5Q58702494-FB0C0B37-02FF-4E48-BC5D-0825431B2255
P2860
NAC-1 controls cell growth and survival by repressing transcription of Gadd45GIP1, a candidate tumor suppressor
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@ast
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@en
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@en-gb
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@nl
type
label
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@ast
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@en
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@en-gb
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@nl
prefLabel
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@ast
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@en
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@en-gb
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@nl
P2093
P1433
P1476
NAC-1 controls cell growth and ...... , a candidate tumor suppressor
@en
P2093
Ie-Ming Shih
Kentaro Nakayama
Naomi Nakayama
Tian-Li Wang
P304
P356
10.1158/0008-5472.CAN-07-1357
P407
P577
2007-09-01T00:00:00Z